Archive - May 2019
Pfizer buys dwarfism drug company Therachon for $810m
Q&A with Tim Cockroft
Medicines Discovery Catapult to collaborate with LifeArc on new biomarkers
Waylivra granted conditional marketing authorisation in Europe
AMR could cause 10 million deaths per year by 2050
Pfizer’s Vyndaqel, Vyndamax win US nod for rare disease
EU approval for Palynziq in adult phenylketonuria
AZ’ Calquence trial to stop early after hitting endpoints